- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
Salflu
Dry Powder Inhalation Capsule (DPI)
Generic Name
Salmeterol + Fluticasone Propionate
Manufacturer
ACME Laboratories Ltd.
Unit Price
Unit Price: ৳ 17.00 (3 x 10: ৳ 510.00) Strip Price: ৳ 170.00
🔹 Indications
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
🔹 Pharmacology
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Dosage & Administration
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Interaction
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Contraindications
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Side Effects
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Pregnancy & Lactation
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Precautions & Warnings
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Pediatric Usage
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Storage Conditions
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
💡 Frequently Asked Questions
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sho...
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sho...
Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sho...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.